Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorAin Shams Maternity Hospital

About this trial

The goal of this observational study is to learn about the effects of the different drug regimens of magnesium sulphate in treatment of (severe pre-eclampsia). This condition affects some pregnant women and raises their blood pressure. It may also cause seizures (fits). The medication (magnesium sulphate) helps to prevent seizures. The main question this study aims to answer is:

What are the different regimens of magnesium sulphate that are used to prevent seizures in pregnant women with severe pre-eclampsia?

Participants already have taken the magnesium sulphate as part of their regular medical care for severe pre-eclampsia. Researchers will look into the records of the participants in the past 5 years to collect the data.

Eligibility criteria

Qualifiers

All hospital records of patients diagnosed as preeclampsia with severe features planned to receive magnesium sulphate.

Disqualifiers

Records with missing data about the regimen of magnesium sulphate used

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

400 Participants
are grouped into 1 trial group

Sponsors and collaborators

Ain Shams Maternity Hospital

Lead sponsor

Ain Shams University

Sponsor institution